Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.15
0.08 (3.86%)
At close: Aug 15, 2025, 9:56 AM
Esperion Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 82.39M | 65M | 69.11M | 51.63M | 73.83M | 137.74M | 32.25M | 33.97M | 25.79M | 24.33M | 18.82M | 18.98M | 18.84M | 18.84M | 15.4M | 14.41M | 40.66M | 7.98M |
Cost of Revenue | 20.61M | 31.54M | 25.63M | 17.29M | 15.61M | 10.07M | 11.45M | 13.38M | 6.79M | 11.65M | 4.16M | 6.51M | 9.18M | 7.13M | 5.08M | 5.56M | 1.8M | 1.78M |
Gross Profit | 61.78M | 33.46M | 43.48M | 34.35M | 58.23M | 127.66M | 20.8M | 20.59M | 19M | 12.68M | 14.66M | 12.47M | 9.66M | 11.71M | 10.33M | 8.85M | 38.86M | 6.19M |
Operating Income | 15.03M | -22.1M | -4.42M | -16.03M | 2.58M | 72.27M | -42.37M | -27.53M | -37.06M | -48.6M | -42.51M | -41.62M | -52.38M | -42.99M | -55.63M | -55.74M | -32.53M | -82.82M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.79M | -40.45M | -21.32M | -29.52M | -61.92M | 61.02M | -56.34M | -41.25M | -49.94M | -61.72M | -55.49M | -55.12M | -66.32M | -56.73M | -65.12M | -69.39M | -43.67M | -90.94M |
Net Income | -4.79M | -40.45M | -21.32M | -29.52M | -61.92M | 61.02M | -56.34M | -41.25M | -49.94M | -89.22M | -68.46M | -68.61M | -80.27M | -70.47M | -65.12M | -69.39M | -43.67M | -90.94M |
Selling & General & Admin | 39.51M | 43M | 36.92M | 39.98M | 44.19M | 41.99M | 45.42M | 33.24M | 33.96M | 29.9M | 24.14M | 24.95M | 29.61M | 30.38M | 38.34M | 39.27M | 46.32M | 61.06M |
Research & Development | 7.24M | 12.56M | 10.98M | 10.4M | 11.46M | 13.4M | 17.74M | 14.88M | 22.1M | 31.38M | 33.03M | 29.14M | 32.43M | 24.32M | 27.62M | 25.33M | 25.07M | 27.95M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 318K | 320K | n/a | 13K | 9K | 14K |
Operating Expenses | 46.75M | 55.55M | 47.9M | 50.37M | 55.65M | 55.39M | 63.16M | 48.13M | 56.06M | 61.28M | 57.17M | 54.1M | 62.04M | 54.7M | 65.95M | 64.6M | 71.39M | 89.02M |
Interest Expense | 20.49M | 19.43M | 16.42M | 15.08M | 13.72M | 14.02M | 15.06M | 14.99M | 14.54M | 14.39M | 14.33M | 14.15M | 14.27M | 14.06M | 13.43M | 13.65M | 11.14M | 8.13M |
Selling & Marketing Expenses | n/a | n/a | 25.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.3M | n/a | n/a | n/a | 13.7M | n/a | n/a | n/a |
Cost & Expenses | 67.36M | 87.09M | 73.53M | 67.66M | 71.25M | 65.47M | 74.62M | 61.5M | 62.84M | 72.93M | 61.33M | 60.6M | 71.22M | 61.83M | 71.03M | 70.15M | 73.19M | 90.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -41K | n/a | -26K | -51K | 27.5M | 12.97M | 13.49M | 13.95M | 13.74M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 196.84M | 196.13M | 195.57M | 194.93M | 188.79M | 169.26M | 112.4M | 111.87M | 109.24M | 78.44M | 73.49M | 67.81M | 63.23M | 60.95M | 36.85M | 26.46M | 26.23M | 25.99M |
Shares Outstanding (Diluted) | 196.84M | 196.13M | 195.57M | 194.93M | 188.79M | 189.64M | 112.4M | 111.87M | 109.24M | 78.44M | 73.49M | 67.81M | 63.23M | 60.95M | 36.85M | 26.46M | 26.23M | 25.99M |
EPS (Basic) | -0.02 | -0.21 | -0.11 | -0.15 | -0.33 | 0.36 | -0.5 | -0.37 | -0.46 | -1.14 | -0.93 | -1.01 | -1.27 | -1.16 | -1.77 | -2.62 | -1.67 | -3.5 |
EPS (Diluted) | -0.02 | -0.21 | -0.11 | -0.15 | -0.33 | 0.34 | -0.5 | -0.37 | -0.46 | -1.14 | -0.93 | -1.01 | -1.27 | -1.16 | -1.77 | -2.62 | -1.67 | -3.5 |
EBITDA | 15.7M | -21M | -4.87M | -14.42M | -48.19M | 75.05M | -41.28M | -26.23M | -35.35M | -47.25M | -41.07M | -40.86M | -51.91M | -42.52M | -51.54M | -55.58M | -32.37M | -82.66M |
EBIT | 15.7M | -21.02M | -4.9M | -14.44M | -48.2M | 75.05M | -41.29M | -26.25M | -35.4M | -47.33M | -41.16M | -40.96M | -52.06M | -42.67M | -51.69M | -55.73M | -32.52M | -82.81M |
Depreciation & Amortization | -26K | 26K | 27K | 26K | 10K | 41K | 6K | 26K | 51K | 81K | 92K | 105K | 150K | 153K | 153K | 153K | 153K | 153K |